N/A N=12 Dental Office Prevention Strategies for Children
Dental Plaque
Primary: Dental Plaque Levels Measures on Scale of 0-2 — 0.391 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=100 Technique for Successful Ultrasound-guided Peripheral Vascular Access
Obesity · Vascular Diseases
Primary: Successful First Attempt Peripheral Venous Cannulation — 96 participants
N/A N=721 Spurring Innovation to Promote HIV Testing: An RCT Evaluating Crowdsourcing
HIV
Primary: First-Time HIV Testing — 111; 114 Participants
Phase 2 N=91 A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
Anemia
Primary: Median Change From Baseline in Hemoglobin Levels to End of Initial Treatment Under Constant Dosing Regimen — -0.29; -0.92; -0.04; -0.46 g/dL
N/A N=68 EEG Biofeedback Therapy as an Adjunct Treatment for PTSD
PTSD · Anxiety · Trauma
Primary: Improved Symptom Ratings — -2.62; -1.62; -2.25; -1.21 Rating on scale
Phase 4 N=5 Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome
Acute Coronary Syndrome · Sleep Disorder
Primary: Changes in Circulating Inflammatory Cytokines (Interleukin [IL]-1B, IL-6, IL-10, and Tumor Necrosis Alpha [TNF-α]) and Pro-coagulant Mediators (Soluble P-selectin and…
N/A N=142 A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain
Adult Intracranial Tumor · Adult Solid Tumor
Primary: Hemodynamics — 98; 88 mmHg — p=< 0.001
N/A N=75 GlideScope Video Laryngoscope Versus Fiberoptic Intubation
Oral Intubation
Primary: Time to Intubation (TTI) as Measured in Seconds — 43; 37 seconds — p=0.19
Phase 2 N=137 A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.
Anemia
Primary: Median Change From Baseline in Hemoglobin Levels to End of Initial Treatment Under Constant Dosing Regimen — -0.80; -0.60; -0.29; 0.02 gram per deciliter
N/A N=58 A Pilot Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Intermittent Exotropia
Primary: Mean Distance Exotropia Control Score — 2.0; 2.8 points on control score scale — p=0.01
Phase 4 N=24 Management of Mandibular ORN: PENTO as Medical Treatment
Osteoradionecrosis
Primary: Bone and/or Tissue Healing as Measured With the Classification of ORN Stages, Area of Bone Exposed (mm2) and Radiological Findings (OPG). — 14; 15; 13; 15 mm2
N/A N=53 Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).
Spinal Cord Injury
Primary: Percentage of Subjects Able to Complete the 600 Meter Walk Test (600MWT) — 95.6 percentage of participants
N/A N=31 MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications
Schizophrenia
Primary: Adherence to Antipsychotic Medications — 92.6; 93.4 percentage of days adherent — p=0.5580
Phase 2 N=24 Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease
Sickle Cell Disease
Primary: Change in Frequency of Vaso-occlusive Pain Events, Before and After Treatment With Simvastatin — 0.2365; 0.1311 proportion of pain days — p=0.005
Phase 2 N=40 Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Malignant Brain Tumors
Primary: Number of Participants With Objective Response — 2; 2; 4; 19 Participants